Psychopharmacology and psychotherapy in the treatment of anxiety.
Freedman
A M
AM
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000628:therapy*; D001569:Benzodiazepines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003071:Cognition; D003131:Combined Modality Therapy; D004311:Double-Blind Method; D006801:Humans; D006990:Hypnosis; D007099:Imipramine / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010200:Panic / Q000187:drug effects; D010634:Phenobarbital / Q000627:therapeutic use; D010698:Phobic Disorders / Q000188:drug therapy; D011613:Psychotherapy / Q000379:methods; D012064:Relaxation Therapy
D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D008996:Monoamine Oxidase Inhibitors; D001569:Benzodiazepines; D007099:Imipramine; D010634:Phenobarbital